ACTRN12610000780055已完成2 期
The effects on insulin-like growth factor 1 (IGF-1) and growth hormone levels using Pioglitazone in the treatment of active acromegaly
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Active acromegaly - clinical features, elevated IGF-1 and/or non-suppressible growth hormone (>1mcg/L) after 75g oral glucose.
排除标准
- •Initiation or discontinuation of octreotide in the last 6 months
- •Initiation or discontinuation of cabergoline in the last 3 months if treatment caused >20% change in serum IGF-1
- •Congestive heart failure (New York Heart Association (NYHA)Grade 2 or above)
- •Current thiozolidinedione use
- •Current malignancy
- •Clinical liver disease
研究者
相似试验
尚未招募
Unknown
Role of Inflammatory markers in different grades of Diabetic Foot UlcerCTRI/2023/07/055588Dr Shaheen B Shaikh
招募中
不适用
Efficacy of Insulin Like Growth Factor-1(IGF-1) on Bone Regeneration in Intrabony Defects : A Clinico-radiograph StudyIntrabony Periodontal DefectNCT06426524Dr R Viswa Chandra24
已完成
不适用
Assessment of serum level of insulin-like growth factor 1 in the Blood of gastric cancer patientsGastric cancer.Stomach, unspecifiedIRCT2016080318745N10Tehran University of Medical Sciences75
已完成
4 期
Effects of Sandostatin LAR® in AcromegalyAcromegalyNCT01424241Columbia University21
尚未招募
Unknown
In this study healthy children and adolescents of 5-16 years are group are taken to determine chronological age bone age and correlate them with serum IGF-1 levels.CTRI/2024/05/067782Jawaharlal Nehru Medical College, KLE University, Belagavi